Continuous Renal Replacement Therapy (CRRT) Market 2028 By Product, Mode | The Insight Partners

report image

Continuous Renal Replacement Therapy (CRRT) Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Systems, Dialysates & Replacement Fluids, Disposables); Mode (Continuous Venovenous Hemodialysis, Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodiafiltration, Slow Continuous Ultrafiltration)

Report Code: TIPHE100001251 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming


Renal replacement therapy includes alternating hemodialysis, peritoneal dialysis, continuous renal replacement therapies (CRRTs), and hybrid therapies such as prolonged alternating renal replacement therapies (PIRRTs), which are prolonged alternating dialysis. Continuous renal replacement therapy (CRRT) is a dialysis technique used to treat critically sick, hospitalized patients admitted in the intensive care unit, which generally develops Acute Kidney Injury (AKI).


The "Global Continuous Renal Replacement Therapy (CRRT) Market Analysis to 2028" is a specialized and in-depth study of the food and beverages industry with a special focus on the global market trend analysis. The report aims to provide an overview of the continuous renal replacement therapy (CRRT) market with detailed market segmentation by product, mode, and geography. The report provides key statistics on the market status of the leading continuous renal replacement therapy (CRRT) market players and offers key trends and opportunities in the market.


  •   Based on product, the global continuous renal replacement therapy (CRRT) market is segmented into bags, accessories.
  •   Based on mode, the global continuous renal replacement therapy (CRRT) market is segmented into ileostomy, colostomy, urostomy.



  •   Increasing global incidence of acute kidney injury (AKI)
  •   Clinical advantages of CRRT over intermittent blood purification techniques
  •   Technological advancements and increasing automation by several companies.


  •   High procedural cost of CRRT


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The continuous renal replacement therapy (CRRT) market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the continuous renal replacement therapy (CRRT) market in these regions.


COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. Several patients with COVID-19 admitted to the ICU show signs of kidney failure and need continuous renal replacement therapy (CRRT); hence the COVID-19 has positively impacted the market. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.


The report covers key developments in the continuous renal replacement therapy (CRRT) market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The impact of SARS-CoV-2 has changed across nations with alternating cardiovascular indications. The market payers from continuous renal replacement therapy (CRRT) market are anticipated to lucrative growth opportunities in the future with the rising demand for continuous renal replacement therapy (CRRT) in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the continuous renal replacement therapy (CRRT) market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •   B. Braun Melsungen AG
  •   Baxter
  •   NIPRO
  •   Fresenius Medical Care AG & Co. KGaA
  •   NxStage Medical, Inc.
  •   SWS Hemodialysis Care Co., Ltd.
  •   Medtronic
  •   Proxima Medicare
  •   Nikkiso Co., Ltd.

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
The List of Companies

1. B. Braun Melsungen AG
2. Baxter
4. Fresenius Medical Care AG & Co. KGaA
5. NxStage Medical, Inc.
6. SWS Hemodialysis Care Co., Ltd.
8. Medtronic
9. Proxima Medicare
10. Nikkiso Co., Ltd.
11. Infomed SA
12. Medica S.p.A.
13. Medical Components, Inc.
14. Medites Pharma spol. s.r.o.
15. CytoSorbents Corporation
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market

Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount